Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHC

Journal of Immunological Methods

Volumn 277, Issue 1-2, 2003, Pages 39-52

  Cohen, Cyril J ^a   Denkberg, Galit ^a   Schiffenbauer, Yael S ^b   Segal, Dina ^a   Trubniykov, Ella ^b   Berke, Gideon ^c   Reiter, Yoram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Medis EL Technologies Ltd   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cancer; CellScan; CTL; Peptide MHC tetramers

Indexed keywords

GAMMA INTERFERON; PEPTIDE; TETRAMER;

ACCURACY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMETRY; DATA ANALYSIS; DEVICE; ELECTRON MICROSCOPY; FLUORESCENCE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0038208180     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00110-8     Document Type: Article

References (32)

1. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
2. Bieganowska K., Hollsberg P., Buckle G.J., Lim D.G., Greten T.F., Schneck J., Altman J.D., Jacobson S., Ledis S.L., Hanchard B., Chin J., Morgan O., Roth P.A., Hafler D.A. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J. Immunol. 162:1999;1765-1771.
3. Bromley S.K., Burack W.R., Johnson K.G., Somersalo K., Sims T.N., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse. Annu. Rev. Immunol. 19:2001;375-396.
4. Cercek L., Cercek B. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review. Eur. J. Cancer. 13:1977;903-915.
5. Cochran J.R., Stern L.J. A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions. Chem. Biol. 7:2000;683-696.
6. Cochran J.R., Cameron T.O., Stern L.J. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity. 12:2000;241-250.
7. Davis M.M., Boniface J.J., Reich Z., Lyons D., Hampl J., Arden B., Chien Y. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16:1998;523-544.
8. Denkberg G., Cohen C.J., Segal D., Kirkin A.F., Reiter Y. Recombinant human single-chain MHC-peptide complexes made from E. coli by in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens. Eur. J. Immunol. 30:2000;3522-3532.
9. Denkberg G., Cohen C.J., Reiter Y. Critical role for cd8 in binding of mhc tetramers to tcr: cd8 antibodies block specific binding of human tumor-specific mhc-peptide tetramers to tcr. J. Immunol. 167:2001;270-276.
10. Deutsch M., Weinreb A. Apparatus for high-precision repetitive sequential optical measurement of living cells. Cytometry. 16:1994;214-226.
11. Deutsch M., Zurgil N., Kaufman M., Berke G. Fluorescence polarization as an early measure of T-lymphocyte stimulation. Methods Mol. Biol. 134:2000;221-242.
12. Dudley M.E., Ngo L.T., Westwood J., Wunderlich J.R., Rosenberg S.A. T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes. Cancer J. 6:2000;69-77.
13. Duportail G., Weinreb A. Photochemical changes of fluorescent probes in membranes and their effect on the observed fluorescence anisotropy values. Biochim. Biophys. Acta. 736:1983;171-177.
14. Eisenthal A., Marder O., Lifschitz-Mercer B., Skornick Y., Tirosh R., Weinreb A., Deutsch M. Inhibition of mitogen-induced changes in intracellular fluorescein fluorescence polarization of human peripheral blood lymphocytes by colchicine, vinblastine and cytochalasin B. Cell Struct. Funct. 21:1996;159-166.
15. Eisenthal A., Marder O., Dotan D., Baron S., Lifschitz-Mercer B., Chaitchik S., Tirosh R., Weinreb A., Deutsch M. Decrease of intracellular fluorescein fluorescence polarization (IFFP) in human peripheral blood lymphocytes undergoing stimulation with phytohaemagglutinin (PHA), concanavalin A (ConA), pokeweed mitogen (PWM) and anti-CD3 antibody. Biol. Cell. 86:1996;145-150.
16. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:1993;403-450.
17. Judd B.A., Koretzky G.A. Antigen specific T lymphocyte activation. Rev. Immunogenet. 2:2000;164-174.
18. Kambayashi T., Ichihara F., Jensen P.E., Ljunggren H.G. Soluble MHC class I molecules induce cellular death in a CD8+ T-cell hybridoma tumor model. Int. J. Cancer. 91:2001;373-378.
19. Kaplan M.R., Trubniykov E., Berke G. Fluorescence depolarization as an early measure of T lymphocyte stimulation. J. Immunol. Methods. 201:1997;15-24.
20. Kirkin A.F., Thor S.P., Hansen M.R., Barfoed A., Dzhandzhugazyan K.N., Zeuthen J. Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones. Cancer Immunol. Immunother. 48:1999;239-246.
21. Lanzavecchia A., Lezzi G., Viola A. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell. 96:1999;1-4.
22. Lee P.P., Yee C., Savage P.A., Fong L., Brockstedt D., Weber J.S., Johnson D., Swetter S., Thompson J., Greenberg P.D., Roederer M., Davis M.M. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:1999;677-685.
23. Lenz B.R. Membrane 'fluidity' as detected by diphenyl hexatriene probes. Chem. Phys. Lipids. 50:1989;171-179.
24. Marder O., Shoval S., Eisenthal A., Fireman E., Skornick Y., Lifschitz-Mercer B., Tirosh R., Weinreb A., Deutsch M. Effect of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha on the intracellular fluorescein fluorescence polarization of human lung fibroblasts. Pathobiology. 64:1996;123-130.
25. Matsumura M., Fremont D.H., Peterson P.A., Wilson I.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science. 257:1992;927-934.
26. Ogg G.S., McMichael A.J. HLA-peptide tetrameric complexes. Curr. Opin. Immunol. 10:1998;393-396.
27. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., Segal J.P., Cao Y., Rowland-Jones S.L., Cerundolo V., Hurley A., Markowitz M., Ho D.D., Nixon D.F., McMichael A.J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:1998;2103-2106.
28. Rammensee H.G., Falk K., Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:1993;213-244.
29. Romero P., Dunbar P.R., Valmori D., Pittet M., Ogg G.S., Rimoldi D., Chen J.L., Lienard D., Cerottini J.C., Cerundolo V. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188:1998;1641-1650.
30. Schiffenbauer Y.S., Trubniykov E., Zacharia B., Gerbat S., Rehavi Z., Berke G., Chaitchik S. Tumor sensitivity to anti-cancer drugs predicted by changes in fluorescence intensity and polarization in vitro. Anticancer Res. 22:2002;2663-2670.
31. Wang B., Maile R., Greenwood R., Collins E.J., Frelinger J.A. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells. J. Immunol. 164:2000;1216-1222.
32. Zurgil N., Deutsch M., Tirosh R., Brodie C. Indication that intracellular fluorescence polarization of T lymphocytes is cell cycle dependent. Cell Struct. Funct. 21:1996;271-276.